Literature DB >> 24042096

Mice with human livers.

Markus Grompe1, Stephen Strom.   

Abstract

Animal models are used to study many aspects of human disease and to test therapeutic interventions. However, some very important features of human biology cannot be replicated in animals, even in nonhuman primates or transgenic rodents engineered with human genes. Most human microbial pathogens do not infect animals and the metabolism of many xenobiotics is different between human beings and animals. The advent of transgenic immune-deficient mice has made it possible to generate chimeric animals harboring human tissues and cells, including hepatocytes. The liver plays a central role in many human-specific biological processes and mice with humanized livers can be used to model human metabolism, liver injury, gene regulation, drug toxicity, and hepatotropic infections.
Copyright © 2013 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  2-(2-nitro-4-trifluoro-methylbenzoyl)-1,3-cyclohexanedione; AFC8; Animal Model; CYP; Chimera; FKBP-Caspase 8 gene driven by the albumin promoter; FRG; Fah; Fah/Rag2/interleukin common gamma chain knockout; Hepatocyte; Humanization; Liver; NOD; NTBC; SCID; TK-NOG; albumin thymidine kinase transgenic-NOD-SCID-interleukin common gamma chain knockout; cytochrome; fumarylacetoacetate hydrolase; non-obese diabetic; severe combined immunodeficiency; uPA; uroplasminogen activator

Mesh:

Substances:

Year:  2013        PMID: 24042096     DOI: 10.1053/j.gastro.2013.09.009

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  47 in total

1.  Higher Serum Alanine Transaminase Levels in Male Urokinase-Type Plasminogen Activator-Transgenic Mice Are Associated With Improved Engraftment of Hepatocytes but not Liver Sinusoidal Endothelial Cells.

Authors:  Marina E Fomin; Ashley I Beyer; Jean Publicover; Kai Lu; Sonia Bakkour; Graham Simmons; Marcus O Muench
Journal:  Cell Med       Date:  2016-11-23

2.  Fibroblast Growth Factor Signaling Controls Liver Size in Mice With Humanized Livers.

Authors:  Willscott E Naugler; Branden D Tarlow; Lev M Fedorov; Matthew Taylor; Carl Pelz; Bin Li; Jennifer Darnell; Markus Grompe
Journal:  Gastroenterology       Date:  2015-05-29       Impact factor: 22.682

Review 3.  Improving external beam radiotherapy by combination with internal irradiation.

Authors:  A Dietrich; L Koi; K Zöphel; W Sihver; J Kotzerke; M Baumann; M Krause
Journal:  Br J Radiol       Date:  2015-03-18       Impact factor: 3.039

4.  In Atp7b-/- Mice Modeling Wilson's Disease Liver Repopulation With Bone Marrow-Derived Myofibroblasts or Inflammatory Cells and Not Hepatocytes Is Deleterious.

Authors:  Yogeshwar Sharma; Jinghua Liu; Kathleen E Kristian; Antonia Follenzi; Sanjeev Gupta
Journal:  Gene Expr       Date:  2018-07-20

Review 5.  Antifibrotic therapies in the liver.

Authors:  W Z Mehal; D Schuppan
Journal:  Semin Liver Dis       Date:  2015-05-14       Impact factor: 6.115

Review 6.  Hepatocellular carcinoma mouse models: Hepatitis B virus-associated hepatocarcinogenesis and haploinsufficient tumor suppressor genes.

Authors:  Yuan-Chi Teng; Zhao-Qing Shen; Cheng-Heng Kao; Ting-Fen Tsai
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

7.  Knockdown of Anillin Actin Binding Protein Blocks Cytokinesis in Hepatocytes and Reduces Liver Tumor Development in Mice Without Affecting Regeneration.

Authors:  Shuyuan Zhang; Liem H Nguyen; Kejin Zhou; Ho-Chou Tu; Alfica Sehgal; Ibrahim Nassour; Lin Li; Purva Gopal; Joshua Goodman; Amit G Singal; Adam Yopp; Yu Zhang; Daniel J Siegwart; Hao Zhu
Journal:  Gastroenterology       Date:  2017-12-21       Impact factor: 22.682

8.  Humanized mice efficiently engrafted with fetal hepatoblasts and syngeneic immune cells develop human monocytes and NK cells.

Authors:  Eva Billerbeck; Michiel C Mommersteeg; Amir Shlomai; Jing W Xiao; Linda Andrus; Ankit Bhatta; Koen Vercauteren; Eleftherios Michailidis; Marcus Dorner; Anuradha Krishnan; Michael R Charlton; Luis Chiriboga; Charles M Rice; Ype P de Jong
Journal:  J Hepatol       Date:  2016-05-02       Impact factor: 25.083

9.  Human hepatocyte transplantation corrects the inherited metabolic liver disorder arginase deficiency in mice.

Authors:  Stephanie A K Angarita; Brian Truong; Suhail Khoja; Matthew Nitzahn; Abha K Rajbhandari; Irina Zhuravka; Sergio Duarte; Michael G Lin; Alex K Lam; Stephen D Cederbaum; Gerald S Lipshutz
Journal:  Mol Genet Metab       Date:  2018-04-21       Impact factor: 4.797

10.  FXR activation by obeticholic acid or nonsteroidal agonists induces a human-like lipoprotein cholesterol change in mice with humanized chimeric liver.

Authors:  Romeo Papazyan; Xueqing Liu; Jingwen Liu; Bin Dong; Emily M Plummer; Ronald D Lewis; Jonathan D Roth; Mark A Young
Journal:  J Lipid Res       Date:  2018-03-20       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.